Search Results - "MOAYEDI, Y."

Identification of risk epitope mismatches associated with de novo donor‐specific HLA antibody development in cardiothoracic transplantation by McCaughan, J. A., Battle, R. K., Singh, S. K. S., Tikkanen, J. M., Moayedi, Y., Ross, H. J., Singer, L. G., Keshavjee, S., Tinckam, K. J.

“…The development of de novo donor‐specific HLA antibodies (dnDSA) after transplantation is associated with graft failure, mortality, and cost. There is no…”
Get full text

The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation by MOAYEDI, Y., TRUBY, L.K., FOROUTAN, F., HAN, J., GUZMAN, J., ANGLEITNER, P., SABATINO, M., FELIUS, J., VAN ZYL, J.S., RODENAS-ALESINA, E., FAN, C-P., DEVORE, A.D., MILLER, R., POTENA, L., ZUCKERMANN, A., FARRERO, M., CHIH, S., FARR, M., HALL, S., ROSS, H.J., KHUSH, K.K.

“…Primary graft dysfunction (PGD) is the leading cause of morbidity and mortality early after heart transplantation (HT). The International Consortium on PGD is…”
Get full text

You Can't Find What You Aren't Looking For: Over Half of Heart Transplant Patients Have Moderate or Strong Likelihood of Genetic Disease by Moscarello, T.G., Moayedi, Y., Caleshu, C., Khush, K., Purewal, S., Teuteberg, J.

“…Approximately half of patients undergoing heart transplant (HTX) have a primary cardiomyopathy. There is growing evidence for a genetic basis in many primary…”
Get full text

6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients by Puing, A., Couture-Cosette, A., Quintero, O., Multani, A., Henricksen, E., Lee, R., Foroutan, F., Moayedi, Y., Teuteberg, J., Subramanian, A.

“…Cytomegalovirus (CMV) infection frequently affects CMV-mismatched (D+/R-) heart transplant (HTx) recipients. Guidelines recommend 3 to 6 months of CMV…”
Get full text

Reducing the Burden of Biopsy: An Institutional Time Series Analysis by Moayedi, Y., Henricksen, E., Purewal, S., Somerset, E., Fan, S., Town, K., Tremblay-Gravel, M., Ross, H.J., Woo, J.Y., Khush, K.K., Teuteberg, J.J.

“…Acute rejection is an important complication following Heart Transplant (HT). The widespread use of peripheral blood markers can reduce the burden of biopsies…”
Get full text

Are Two Tests Better Than One? Combining Donor Derived Cell-Free DNA and Gene Expression Profiling for Non-Invasive Surveillance after Heart Transplantation by Purewal, S., Moayedi, Y., Runeckles, K., Fan, C., Gordon, J., Henricksen, E.J., Oro, G., Shudo, Y., Khush, K.K., Teuteberg, J.

“…Endomyocardial biopsy (EMBx) is the gold standard for acute cellular rejection (ACR) after heart transplantation (HTx). However, the limitations of EMBx has…”
Get full text

Incidence and Impact of Primary Graft Dysfunction in Adult Heart Transplant Recipients: A Systematic Review and Meta-Analysis by Buchan, T.A., Moayedi, Y., Truby, L.K., Posada, J. Duero, Ross, H.J., Alba, A.C., Foroutan, F.

“…Primary graft dysfunction (PGD) is a life-threatening complication and a leading cause of early mortality post heart transplant (HTx). Recent studies…”
Get full text

Predictors of Survival in Patients with Cardiac Amyloidosis by Moayedi, Y, Duero, J.P, Foroutan, F, Alba, A.C, Ross, H.J, Delgado, D

Get full text

Take the First Available Heart: Use of Higher-Risk Donors in Recipients with Pre-Transplant Mechanical Circulatory Support by Han, J., Moayedi, Y., Yang, W., Henricksen, E.J., Lee, R., Purewal, S., Chang, E., Duclos, S., Lyapin, A., Feng, K.Y., Hiesinger, W., Teuteberg, J.J., Khush, K.K.

“…Availability of heart transplantation (HTx) is limited by donor supply. We evaluated the post-transplant outcomes of higher-risk organs in recipients supported…”
Get full text

Can Too Much Be Bad: Aggressively Lowering LDL Not Associated with Improvement in Maximal Intimal Thickening by Lee, R., Henricksen, E.J., Moayedi, Y., Runeckles, K., Fan, C.S., Han, J., Feng, K.Y., Yang, W., Town, K., Marks, P., MacArthur, J.W., Khush, K.K., Teuteberg, J.J.

“…Statins are the only Class I ISHLT recommendation in heart transplantation (HT) as an established therapy to reduce cardiac allograft vasculopathy (CAV) and…”
Get full text

Severe Primary Graft Dysfunction: Impact of the New UNOS Heart Allocation System by Han, J., Moayedi, Y., Yang, W., Henricksen, E.J., Lee, R., Purewal, S., Chang, E., Duclos, S., Lyapin, A., Tremblay-Gravel, M., Alexander, K.M., Kawana, M., Hiesinger, W., Teuteberg, J.J., Khush, K.K.

“…Primary graft dysfunction (PGD) is a leading cause of early morbidity and mortality following heart transplantation (HTx). The purpose of this study was to…”
Get full text

Run for It: Use of Cardiopulmonary Exercise Testing for Hemodynamic Assessment in Advanced Heart Failure by Moayedi, Y., Tremblay-Gravel, M., Somerset, E., Fan, C.S., Yang, W.A., Henricksen, E.J., Christle, J.W., Haddad, F., Khush, K.K., Ross, H.J., Teuteberg, J.J.

“…Cardiopulmonary exercise testing (CPET) is an underutilized resource in the assessment of advanced heart failure (HF) after listing for heart transplant (HT)…”
Get full text

Corrigendum to “Conditional loss of Spata7 in photoreceptors causes progressive retinal degeneration in mice” [Exp. Eye Res. 166 (2018) 120–130] by Eblimit, A., Agrawal, S.A., Thomas, K., Anastassov, I.A., Abulikemu, T., Moayedi, Y., Mardon, G., Chen, R.

Get full text

Acute Cellular Rejection after Heart Transplantation Dramatically Subsequent Risk of Mortality, Particularly among African Americans by Moayedi, Y., Fan, C.S., Purewal, S., Han, J., Yang, W.A., Henricksen, E.J., Feng, K.Y., Duclos, S., Lyapin, A., Lee, R., Chang, E., Gordon, J., Ross, H.J., Khush, K., Teuteberg, J.J.

“…African Americans (AA) have worse survival compared to Caucasians after heart transplantation (HTx). We assessed whether AA are at higher risk of acute…”
Get full text

Moving towards an Induction-Free Era: Short-Term Renal and Infectious Outcomes by Moayedi, Y., Henricksen, E.J., Lafreniere-Roula, M., Fan, C.S., Multani, A., Puing, A., Couture-Cosette, A., Quintero, O., Han, J., Feng, K.Y., Lee, R., Duclos, S., Lyapin, A., Purewal, S., Subramanian, A., Ross, H.J., Hiesinger, W., Khush, K.K., Teuteberg, J.J.

“…Currently, 50% of heart transplant (HTx) programs worldwide use an induction therapy strategy despite limited evidence. Recently, our program moved from…”
Get full text

To SIPAT or Not to SIPAT: The Stanford Integrated Psychosocial Assessment for Transplant by Moayedi, Y., Yang, W.A., Mueller, B., Fan, C.S., Purewal, S., Ramirez, N., Han, J., Henricksen, E.J., Lee, R., Duclos, S., Lyapin, A., Wainwright, R., Hiesinger, W., Ross, H.J., Khush, K.K., Teuteberg, J.J.

“…The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) is a tool used to standardize and objectify the pre-transplant evaluation. We sought to…”
Get full text

Malignancy Following Heart Transplant: Few and Far Between by Chang, E., Moayedi, Y., Hoppenfeld, M., Lafreniere-Roula, M., Fan, S., Henricksen, E.J., Feng, K., Morales, D.P., Purewal, S., Duclos, S., Lee, R., Lyapin, A., Currie, M., Ross, H.J., Teuteberg, J.J., Khush, K.K.

“…De novo malignancy is a threat to long-term survival after heart transplantation (HTx) After five years, along with cardiac allograft vasculopathy (CAV), it is…”
Get full text

Peak Oxygen Consumption as a Prognostic Marker in Patients with Cardiac Amyloidosis by Moayedi, Y, Duero Posada, J.G, Delgado, D.H, Foroutan, F, Schofield, T, Ross, H.J, Alba, A.C

Get full text

AAV8(Y733F)-mediated gene therapy in a Spata7 knockout mouse model of Leber congenital amaurosis and retinitis pigmentosa by Zhong, H, Eblimit, A, Moayedi, Y, Boye, S L, Chiodo, V A, Chen, Y, Li, Y, Nichols, R M, Hauswirth, W W, Chen, R, Mardon, G

“…Loss of SPATA7 function causes the pathogenesis of Leber congenital amaurosis and retinitis pigmentosa. Spata7 knockout mice mimic human SPATA7 –related…”
Get full text

Pulmonary vein stenosis: Case report and literature review by Amin, R, Kwon, S, Moayedi, Y, Sweezey, N

“…Pulmonary vein stenosis is a rare cause of pulmonary hypertension, with variable onset and presentation. One or more of the four pulmonary veins can be…”
Get full text